ANTITUMOR SYNERGISM BETWEEN RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR AND RECOMBINANT HUMAN INTERFERON-R
- 1 February 1988
- journal article
- research article
- Vol. 7 (1) , 24-31
Abstract
We studied the antitumor synergy of human recombinant tumor necrosis factor (TNF) in combination with recombinant interferon-r (IFN-r) both in vitro and in vivo. Synergistic cytotoxic effects were observed in all three of the human tumor cells lines examined. Binding assays of KB human nasopharynx carcinoma cell surface receptors for TNF revealed that IFN-r increased the number of receptors and suggest that this increase may play a key role in the synergism. Furthermore, a remarkable antitumor effect by TNF in combination with IFN-r was observed in nude mice implanted with the cells. The results thus suggest that TNF and IFN-r in combination may provide the basis for a useful antitumor therapeutic regimen.This publication has 7 references indexed in Scilit:
- HUMAN-TUMOR XENOGRAFTS TREATED WITH RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR ALONE OR IN COMBINATION WITH INTERFERONS1986
- Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma.Journal of Biological Chemistry, 1986
- Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.The Journal of Immunology, 1986
- PROPOSAL OF STANDARDIZED METHODS AND REFERENCE FOR ASSAYING RECOMBINANT HUMAN TUMOR NECROSIS FACTORJapanese Journal of Medical Science and Biology, 1986
- Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factorEuropean Journal of Biochemistry, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.Proceedings of the National Academy of Sciences, 1983